These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26973115)

  • 1. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.
    Rettberg JR; Dang H; Hodis HN; Henderson VW; St John JA; Mack WJ; Brinton RD
    Neurobiol Aging; 2016 Apr; 40():155-163. PubMed ID: 26973115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.
    Karim R; Koc M; Rettberg JR; Hodis HN; Henderson VW; St John JA; Allayee H; Brinton RD; Mack WJ
    Menopause; 2019 Jan; 26(1):7-15. PubMed ID: 29975287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women.
    Kurita K; Henderson VW; Gatz M; St John J; Hodis HN; Karim R; Mack WJ
    Fertil Steril; 2016 Sep; 106(3):749-756.e2. PubMed ID: 27183047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.
    Ivanoiu A; Dricot L; Gilis N; Grandin C; Lhommel R; Quenon L; Hanseeuw B
    J Alzheimers Dis; 2015; 43(3):835-47. PubMed ID: 25114071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance.
    Shea TB; Remington R
    J Alzheimers Dis; 2018; 61(3):913-915. PubMed ID: 29332053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicultural Healthy Diet to Reduce Cognitive Decline & Alzheimer's Disease Risk: Study protocol for a pilot randomized controlled trial.
    Mossavar-Rahmani Y; Shaw PA; Hakun JG; Katz MJ; Wylie-Rosett J; Sliwinski MJ
    Contemp Clin Trials; 2023 Jan; 124():107006. PubMed ID: 36396064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of functional tasks exercise on older adults with cognitive impairment at risk of Alzheimer's disease: a randomised controlled trial.
    Law LL; Barnett F; Yau MK; Gray MA
    Age Ageing; 2014 Nov; 43(6):813-20. PubMed ID: 24850540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
    Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
    Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.
    Roalf DR; Quarmley M; Mechanic-Hamilton D; Wolk DA; Arnold SE; Moberg PJ;
    J Alzheimers Dis; 2016 Aug; 54(1):325-35. PubMed ID: 27567827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and cognition, with a focus on Alzheimer's disease.
    Pinkerton JV; Henderson VW
    Semin Reprod Med; 2005 May; 23(2):172-9. PubMed ID: 15852203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular disease, Alzheimer's disease biomarkers and cognition in mild cognitive impairment: additive or synergetic effects?
    Nordlund A; Göthlin M; Wallin A
    Dement Geriatr Cogn Disord; 2011; 32(4):250-6. PubMed ID: 22179302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.